News
Launch of the European COVID-19 Data Platform
On 20 April the Commission together with EU Member States and several partners, including EMBL’s European Bioinformatics Institute (EMBL-EBI) and research partners such as ELIXIR, launched a European COVID-19 Data Platform to enable the collection and sharing of reference data and specialised datasets to accelerate COVID-19 research.
The European Medicines Agency (EMA) published its Regulatory Science Strategy to 2025
On 31 March, the European Medicines Agency (EMA) published its Regulatory Science Strategy to 2025. The new RSS sets out the EMA’s strategic thinking for the advancement of regulatory science over the next five years, incorporating human as well as veterinary medicines.
Avicenna Alliance continues to grow by welcoming Servier among its members
The Avicenna Alliance is happy to welcome its newest member: Servier.
The Avicenna Alliance published new case studies on in silico medicine
The Avicenna Alliance is proud to announce that new Member’s case studies on in silico medicine have been published today!
Quantum technologies are getting momentum in the EU
On February 27 Austria, Bulgaria, Denmark and Romania have agreed to work together with 20 other EU Member States towards the development of a quantum communication infrastructure (QCI) across Europe.
The Avicenna Alliance answers the consultation for Europe’s Beating Cancer Plan
On 3 March 2020, the Avicenna Alliance has submitted feedback on the roadmap of Europe’s Beating Cancer Plan. With this feedback, the Alliance wishes to emphasise the role that computer modelling and simulation can play in the prevention, early detection, diagnosis and knowledge of cancer.
